Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Samin Darou Iranian Company is an Iranian pharmaceutical company established in 2014 and headquartered in Tehran, with manufacturing facilities in Kaveh Industrial City, Saveh. The company specializes in the research, development, and commercial-scale production of Active Pharmaceutical Ingredients (APIs) and pharmaceutical pellets in compliance with Good Manufacturing Practice (GMP) standards. Samin Darou Iranian produces over 17 APIs, including metformin hydrochloride, azithromycin, pantoprazole sodium, and atorvastatin, alongside various delayed-release and sustained-release pellet formulations. As a member of the Vana Darou Gostar holding group, the company supplies high-quality raw materials to major domestic and regional pharmaceutical manufacturers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Samin Daroo Company.